A remarkable new way to tackle deadly drug-resistant infections – by supercharging the body’s own immune cells rather than relying on new medicines – has been developed by scientists.
Antimicrobial resistance (AMR) – where bacteria, viruses, fungi and parasites no longer respond to drug treatments – has become one of the most serious health threats.
In Britain alone, it contributes to 35,000 deaths a year, says the patient charity AMR Action UK.
Common infections that are now resistant to many available medications include urinary tract infections, pneumonia, E.coli, MRSA and C.difficile. The problem has been worsened by the fact that few new antibiotics
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
